logo
Select company
Select metric
5.02Cash Ratio
VS
Market
93
Sector
87
Industry
81
History
68
$ 10.18Close
$ 5.86 - $ 16.56 52-Week Range
Ticker Information

Ticker

CRMD

Company Name

CORMEDIX INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CORMEDIX INC - Cash Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CRMD - Cash Ratio Historical data
DateCash and EquivalentsCash RatioCurrent Liabilities
6/30/2025$ 159.31M5.02$ 31.71M
3/31/2025$ 66.29M1.93$ 34.39M
12/31/2024$ 40.65M1.2$ 33.84M
9/30/2024$ 35.29M1.91$ 18.48M
6/30/2024$ 28.54M2.57$ 11.11M
3/31/2024$ 35.26M3.7$ 9.53M
12/31/2023$ 43.72M3.83$ 11.4M
9/30/2023$ 53.4M6.96$ 7.67M
6/30/2023$ 19.79M2.68$ 7.39M
3/31/2023$ 25.39M5.43$ 4.67M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CORMEDIX INC's latest trailing twelve months (TTM) Cash Ratio stands at 7.51.
  • Over the past 5 years, CORMEDIX INC's average Cash Ratio has been 7.97.
  • The median Cash Ratio for CORMEDIX INC during this period was 6.91
  • CORMEDIX INC reached its highest Cash Ratio over the past 5 years at 25.04.
  • The lowest Cash Ratio recorded by CORMEDIX INC in the same timeframe 1.2

CORMEDIX INC's Cash Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash Ratio Benchmarks
CompanyCash Ratio
NAGE : NIAGEN BIOSCIENCE INC 2.71ZYME : ZYMEWORKS INC 2.55ANAB : ANAPTYSBIO INC 1.25PHAT : PHATHOM PHARMACEUTICALS INC 1.66URGN : UROGEN PHARMA LTD 1.98GYRE : GYRE THERAPEUTICS INC 2.16NRIX : NURIX THERAPEUTICS INC 0.96GERN : GERON CORP 1.24SNDX : SYNDAX PHARMACEUTICALS INC 0.96XNCR : XENCOR INC 0.47

Definition of Cash Ratio

[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for CORMEDIX INC is calculated as follows: CashnEq [ $ 34.55M ] / LiabilitesC [ $ 4.6M ]
(=) Cash Ratio [ 7.51 ]

CRMD - Cash Ratio, Last 5 years

1.2

Minimum

Dec 31, 2024

25.04

Maximum

Mar 31, 2021

7.97

Average

6.91

Median

Cash Ratio Benchmark Analysis

The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
filtered constituents3.13K
min0
max2.69
average0.62
median0.39
std0.63